Background: Diagnosis of left ventricular (LV) diastolic dysfunction by blood testing is expedient in the clinical setting.
eft ventricular (LV) diastolic dysfunction carries a substantial risk of subsequent development of heart failure and reduced survival, even when it is asymptomatic. 1 Thus, early identification of LV diastolic dysfunction in patients without overt symptoms may provide an opportunity to manage the underlying etiology to prevent progression to heart failure with preserved LV ejection fraction (EF). However, quantitative and precise elucidation of LV diastolic dysfunction requires cardiac catheterization of the left ventricle, which is an invasive and potentially complex procedure. In contrast, elevated plasma levels of brain natriuretic peptide (BNP) and N-terminal pro-BNP (NT-proBNP) are known noninvasive parameters of LV diastolic dysfunction. 2-5 Accordingly, we investigated whether LV diastolic dysfunction without apparent symptoms derived from heart failure in patients with preserved LVEF could be identified using the NTproBNP level.
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Study Subjects
The study participants were enrolled from among 115 consecutive patients who underwent diagnostic cardiac catheterization for the evaluation of coronary artery disease, and from whom blood samples for NT-proBNP measurement were taken at cardiac catheterization. All patients had symptoms suggestive of exercise-induced angina pectoris and/or clinical signs of coronary artery disease, including positive exercise electrocardiographic changes, abnormal myocardial perfusion scintigraphic findings, and a history of myocardial infarction or coronary revascularization. No patient had apparent symptoms or signs of heart failure that satisfied the Framingham criteria for the diagnosis of heart failure. 6 A total of 98 patients with LVEF ≥50% by left ventriculography were eligible for enrollment in SONODA H et al.
this study. Patients with renal insufficiency (serum creatinine ≥1.5 mg/dl), atrial fibrillation or flutter, artificial pacemakers, hemodynamically significant valvular disease, conditions after prosthetic valve replacement, idiopathic dilated or hypertrophic cardiomyopathy, or acute coronary syndromes were excluded. According to the findings of coronary angiography and left ventriculography, 29 patients had a previous myocardial infarction, 60 patients had angina pectoris without LV wall motion abnormalities, and 9 patients had atypical chest pain without significant coronary stenosis. In each patient, a body mass index was calculated using the standard formula. All patients provided written informed consent for participation in the study. The study protocol was reviewed by the ethical guidelines committee of Nagoya City University Graduate School of Medical Sciences.
Cardiac Catheterization
LV pressure waves were obtained with a catheter-tipped micromanometer (SPC-454D; Millar Instruments, Houston, TX, USA) and recorded on a polygraph system (RMC-3000; Nihon Kohden, Tokyo, Japan) and on a digital data recorder (NR-2000; Keyence, Osaka, Japan), as we have reported elsewhere. 7, 8 From the recorded pressure waves, a time constant τ of decrease in LV pressure, was computed by applying a monoexponential fitting with zero asymptote to LV pressure decay. 9 The inertia force (IF) was calculated from the LV pressure (LVP)−dP/dt relation (phase loop) according to the method proposed by Sugawara et al; 10 we previously reported that a cause of isolated LV diastolic dysfunction was lack of IF. 7 LV end-systolic and end-diastolic volumes were obtained from biplane left ventriculography using the method proposed by Chapman et al. 11 Next, the patient's LVEF was determined. The LV volumes in each patient were corrected by body surface area and expressed as LV end-systolic and end-diastolic volume indexes. Patients were divided into 2 groups on the basis of their LV relaxation time constant (τ): patients with preserved LV relaxation (τ <48 ms), and those with impaired LV relaxation (τ ≥48 ms). The threshold value of ≥48 ms to distinguish impaired LV relaxation from preserved relaxation was derived from the report by the European Society of Cardiology. 12 We also divided the patients into another 2 groups: patients with the IF of late systolic aortic flow (IF ≥0.5 mmHg) and those without (IF <0.5 mmHg). 7 To assay plasma NT-proBNP, venous blood samples (6 ml) were collected from the right femoral or median cubital vein of each patient at the time of cardiac catheterization. Blood samples were centrifuged and then stored at −70°C. The NTproBNP concentration in blood was measured using a fullyautomated electrochemiluminescence "sandwich" immunoassay for NT-proBNP using a commercially available analyzer (cobas 6000; Roche Diagnostics; Basel, Switzerland). Using this method, the minimal detectable quantity of human NTproBNP is 6 pg/ml.
Statistical Analysis
SPSS version 17.0 (SPSS, Inc, Chicago, IL, USA) was used for statistical analysis. NT-proBNP levels are summarized as medians and interquartile ranges (IQRs). Other data are presented as mean ± SD or frequency (percentage). Parameters were compared between groups using Student's unpaired t-test or Mann-Whitney test as appropriate. Differences in prevalence between groups were also compared using the chi-square test. Relations between 2 parameters were evaluated by univariate linear regression analysis. Because NT-proBNP levels were not normally distributed, a logarithmic transformation was applied. The relationship between the IF and NT-proBNP Data are mean ± standard deviation or frequency. ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium-channel blocker; IF, inertia force; LV, left ventricular; τ, time constant of LV relaxation. NT-ProBNP and LV Diastolic Function level was presented using Spearman's correlation coefficient by rank (non-parametric method). Other correlation coefficients were calculated using Pearson's method. In addition, stepwise multivariate regression analyses were performed to determine which independent variables would significantly affect the log NT-proBNP level. The possible independent variables for determining log NT-proBNP level in the regression model I were age, heart rate, mean blood pressure, LV end-systolic anddiastolic volumes, LV end-diastolic pressure, and serum creatinine. Then, we added female sex, with or without diabetes mellitus, and with or without hypertension to the original independent variables (model II). We further included medication status of the patients shown in Table 1 as an independent parameter (model III). Additional variables were treated as binary categorical parameters in the multiple regression analyses. Furthermore, similar multivariate regression analyses for log NT-proBNP level were conducted using the IF instead of τ, as well as other independent parameters (models IV, V, and VI). In these analyses, the parameter of whether a patient had the IF or not was treated as a categorical parameter, because the IF either did not show parametric distribution or was equal to zero in several patients. The ability of the NT-proBNP level to identify LV diastolic dysfunction was investigated using a receiver-operating characteristic (ROC) curve analysis; the area under the curve and 95% confidence intervals (CI) are indicated. In the ROC curve analyses, we wanted to find the NT-proBNP value for detecting τ ≥48 ms with relatively higher sensitivity and lack of the IF with relatively higher specificity. Differences with P-values <0.05 were considered statistically significant.
Results
Tables 1 and 2 list the baseline characteristics of the patients. No significant differences between patients with preserved LV relaxation and those with impaired LV relaxation were observed regarding age, sex, or mean blood pressure. However, heart rate was significantly slower in patients with impaired LV relaxation than in those with preserved LV relaxation. The incidence of β-blocker therapy was significantly higher among patients in the former group than among patients in the latter group. LVEF was significantly lower in patients with impaired LV relaxation than in those with preserved LV relaxation. LV end-systolic and end-diastolic volume indexes were significantly larger, and end-diastolic pressure was significantly higher, in the former group than in the latter. Data are mean ± standard deviation or frequency. Abbreviations as in Table 1 . Patients without the IF had a significantly longer LV time constant τ, higher LV end-diastolic pressure, and worse LV systolic function than those with the IF. Differences in the baseline clinical characteristics and hemodynamic data between the 2 groups are shown in Table 2 In the univariate regression analysis, the time constant τ of LV relaxation significantly correlated with log NT-proBNP level (r=0.539; P<0.001). The IF, LV end-diastolic pressure, and LV systolic function parameters also significantly correlated with the log NT-proBNP level ( Table 3) . Results of the multivariate regression analyses for log NT-proBNP level are shown in Tables 4 and 5. In the regression analysis model III, the time constant τ, age, body mass index, and heart rate were selected as determinants for log NT-proBNP level after adjusting for other confounders (R 2 =0.480, F=5.619, P<0.001). In the multivariate regression analysis model VI, the IF, age, body mass index, and β-blocker usage were selected as deter- Tables 1,3 . NT-ProBNP and LV Diastolic Function minants for log NT-proBNP level after adjusting for other confounders (R 2 =0.463, F=5.308, P<0.001).
The ROC curve analysis indicated that NT-proBNP level had a significant potential for identifying impaired LV relaxation in patients with preserved LVEF (Figure A) . The area under the curve value for NT-proBNP level to detect patients with impaired LV relaxation was 0.84 (95% CI 0.76-0.91; P<0.001). From this ROC curve, NT-proBNP levels to separate patients with impaired LV relaxation from those with preserved LV relaxation with relatively high sensitivity but low specificity, with moderate sensitivity and specificity, and with low sensitivity but high specificity are shown in Table 6 . All patients with NT-proBNP <56.5 pg/ml had preserved LV relaxation. As shown in Figure B , the area under the curve for NT-proBNP level to detect patients without the IF was 0.89 (95% CI 0.82-0.97; P<0.001). From this ROC curve, NTproBNP levels to distinguish patients without the IF from those with the IF were determined using the same procedure ( Table 7) . NT-proBNP ≥244.5 could identify patients without the IF with relatively low sensitivity but high specificity. 
Discussion
Among the study group of patients with preserved LVEF, we demonstrated that those with impaired LV relaxation (τ ≥48 ms) were potentially distinguished from the those with preserved LV relaxation using NT-proBNP values with particular levels of sensitivity and specificity. In addition, our results also indicate that patients with a lack of the IF of late systolic aortic flow, which causes abnormal LV relaxation through loss of elastic recoil in the LV, were also potentially and similarly identified using different NT-proBNP values. The plasma BNP level can be measured clinically as an evaluation of LV diastolic dysfunction in patients with a wide range of systolic function. 13 In patients with preserved LV systolic function, Lubien et al demonstrated that the plasma BNP level increased with aggravation of LV diastolic dysfunction, which was evaluated from the transmitral flow velocity patterns, 14 although this method is less sensitive for the identification of LV diastolic dysfunction compared with the established invasive method. Iwanaga et al reported that in patients with heart failure, the plasma BNP level increased in relation to elevated LV end-diastolic stress or end-diastolic pressure, 15 and Yamamoto et al have reported that the LV relaxation time constant τ significantly and positively correlated with plasma BNP level. 16 The plasma NT-proBNP level reflects similar LV hemodynamic conditions as observed for the plasma BNP level. 17 However, female sex, body mass index, renal function, and medications have been acknowledged as possible confounders for the NT-proBNP level. 1,18-22 Therefore, multivariate regression analyses were needed in the current study to ascertain whether the LV relaxation time constant τ or the IF could determine the NT-proBNP level. In our multiple regression analysis model III, τ was selected as a prime determinant of log NT-proBNP level, although age, and body mass index, and heart rate also showed significant correlations with the log NT-proBNP level. LV diastolic dysfunction is mainly derived from 2 factors (ie, abnormal relaxation and increased chamber stiffness). 23 Generally, deterioration of LV relaxation precedes the increase in LV chamber stiffness in the process of worsening in LV diastolic function. 24 Patients enrolled in the current study were those who had suspected or definite coronary artery disease and an LVEF ≥50%, indicating that the LV volume was not so large in these patients. In the LV with such conditions, impairment of relaxation should be more evident than elevated chamber stiffness. 24 In the multivariate regression analysis model VI, the IF, age, body mass index, and β-blocker usage were selected as determinants for the log NTproBNP level.
There was no significant difference in age between patients with preserved and impaired LV relaxation or between patients with and without the IF. Hence, the interaction between age and NT-proBNP level was negligible in the ROC curve analyses. Heart rate, body mass index, and β-blocker usage may have affected the ROC curve analyses.
Elevated NT-proBNP levels were significantly related to unfavorable outcomes in heart failure patients with preserved or reduced LVEF in large-scale randomized clinical trial cohorts. [25] [26] [27] In addition, Mckie et al reported that, after adjustment for conventional clinical risk factors, the NT-proBNP level had significant predictive value for mortality and cardiovascular events in the general population in the absence of overt heart failure. 28 Thus, an increased NT-proBNP level has significant potential for prognostication in patients with heart failure and in the general population without overt heart failure. However, there is a limited number of reports about the threshold value used to identify the upper range of NT-proB-NP in healthy subjects and the threshold value to recognize isolated LV diastolic dysfunction with appropriate sensitivity and specificity. According to our knowledge, no report has demonstrated the threshold value of NT-proBNP to identify the preserved LV relaxation that was invasively confirmed as LV time relaxation constant τ <48 ms. The NT-proBNP assay system is provided world-wide by Roche Diagnostics (Basel, Switzerland), and uses a standard threshold value of 125 pg/ml to discriminate patients with heart failure from those without heart failure. This value is based on a report that appeared as an abstract in 2004. 29 Seino et al also reported a normal range of NT-proBNP (23.7±15.4 pg/ml) in 67 healthy subjects (6 women, 61 men; mean age 35.1±12.5 years) in whom blood pressure was less than 140/90 mmHg and the main blood examination parameters were within normal limits. 30 They proposed an upper limit of 54.5 pg/ml NT-proBNP in healthy Japanese subjects. This value was calculated as the mean + 2 SD of the NT-proBNP distribution in the examined subjects, although the distribution of NT-proBNP levels might not be normal.
One parameter that can detect LV diastolic dysfunction in patients with preserved EF is a prolonged LV relaxation time constant (τ ≥48 ms). Another possibility for diagnosing LV diastolic dysfunction in patients with preserved EF is to identify a lack of the IF of late systolic aortic flow. 7 We previously reported that the late systolic aortic flow ejected from a LV with good contraction has IF. 10 Because of inertia, the blood, once set in motion, will continue in motion until stopped by the LV. 31 In late systole, when LV muscle shortening is maximal, but LV tension-bearing ability is still maintained, the inertia of the blood flowing out of the LV causes swift end-systolic unloading of the ventricle, producing a much smaller LV end-systolic volume and a much greater elastic recoil force. 7,10,32 Thus, the IF can be regarded as another aspect of LV elastic recoil that speeds LV relaxation. The enhanced LV elastic recoil force in patients with good LV contraction produces much faster LV relaxation and much faster propagation of the early diastolic filling flow in the LV. 7,32, 33 The IF may be a crucial factor through which good LV systolic function derivers its effect on LV early diastolic function. We consider that a lack of the IF is a significant cause of isolated LV diastolic dysfunction. 7 Lack of the IF does not affect the element of LV relaxation that is produced by the Ca 2+ reuptake process of the sarcoplasmic reticulum, 23 whereas the time constant τ (measured with Weiss's method) reflects both mechanisms. 7, 23 Thus, lack of the IF and τ ≥48 ms reflect different aspects of isolated LV diastolic dysfunction. Based on the higher NT-proBNP level in patients without the IF compared with that observed in patients with τ ≥48 ms, we consider that patients without the IF have relatively advanced LV diastolic dysfunction compared with the patients with τ ≥48 ms.
A NT-proBNP level <56.5 pg/ml to indicate definitely preserved LV relaxation in patients with preserved EF is similar to the normal upper limit of NT-proBNP in healthy Japanese subjects reported by Seino et al (54.5 pg/ml). 30 NT-proBNP level >125 pg/ml, a proposed world-wide range to detect heart failure, is similar to the NT-proBNP value of 126.5 pg/ml by which a lack of the IF is sensitively identified. However, when NT-proBNP ≥126.5 pg/ml is used to distinguish patients without the IF, the specificity and positive predictive value are relatively lower because of the skewed distribution of NTproBNP levels. NT-proBNP ≥244.5 pg/ml improves this problem, with a relatively higher specificity and positive predictive value. In addition, NT-proBNP ≥197.0 pg/ml could detect τ ≥48 ms with moderate specificity and positive predictive value. NT-ProBNP and LV Diastolic Function These 2 values are close to the NT-proBNP level (220 pg/ml) for diagnosing heart failure with preserved EF proposed by the European Society of Cardiology. 12 
Conclusions
In patients with coronary artery disease, NT-proBNP <56.5 pg/ml (not <125 pg/ml) can be used to identify patients with not only preserved LVEF, but with preserved LV relaxation as well. NT-proBNP ≥244.5 pg/ml could be used to identify lack of the IF or LV elastic recoil specifically and may have the potential for specific diagnosis of LV isolated diastolic dysfunction.
